Market research
002773.SHE Chengdu Kanghong Pharmaceuticals Group Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 19B
- P/E ratio
- 18.66
- Analyst target
- 24
- Dividend yield
- 3.5%
- Beta
- -0.2
Community
Investor discussion
1 comment
Sign in to join the 002773.SHE discussion.
5 years, 5 months ago
Chengdu Kanghong Pharmaceuticals Group Co., Ltd is currently in a long term downtrend where the price is trading 37.3% below its 200 day moving average.
From a valuation standpoint, the stock is 20.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.7.
Chengdu Kanghong Pharmaceuticals Group Co., Ltd's total revenue rose by 12.6% to $955M since the same quarter in the previous year.
Its net income has increased by 47.3% to $244M since the same quarter in the previous year.
Finally, its free cash flow grew by 1952.3% to $395M since the same quarter in the previous year.
Based on the above factors, Chengdu Kanghong Pharmaceuticals Group Co., Ltd gets an overall score of 4/5.